RARγ acts as a tumor suppressor in mouse keratinocytes

Oncogene

Volumn 23, Issue 31, 2004, Pages 5350-5359

  Chang, Feng Chen ^a,b   Goyette, Philippe ^b,d   Lohnes, David ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d BioLactis   (Canada)

Author keywords

Keratinocytes; Ras; Retinoic acid receptors; Skin tumorigenesis; Squamous cell carcinoma; Tumor suppressor

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR GAMMA; RETINOL; RAS PROTEIN; RETINOIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HOMEOSTASIS; KERATINOCYTE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ANIMAL; CELL NUCLEUS; CELL STRAIN COS1; GENETICS; GENOTYPE; METABOLISM; PHYSIOLOGY; REPORTER GENE; RETROVIRUS; SKIN TUMOR; TIME; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALIA; MURINAE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; COS CELLS; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; GENOTYPE; KERATINOCYTES; MICE; MICE, TRANSGENIC; RAS PROTEINS; RECEPTORS, RETINOIC ACID; RETROVIRIDAE; SKIN NEOPLASMS; TIME FACTORS; TRETINOIN;

EID: 3442897442     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207682     Document Type: Article

References (86)

1. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ and Sebti SM. (2000). Oncogene, 19, 5338-5347.
2. Altucci L and Gronemeyer H. (2001). Nat. Rev. Cancer, 1, 181-193.
3. Angel P and Karin M. (1992). Matrix. Suppl., 1, 156-164.
4. Berard J, Laboune F, Mukuna M, Masse S, Kothary R and Bradley WE. (1996). FASEB J., 10, 1091-1097.
5. Borriello A, Pietra VD, Criscuolo M, Oliva A, Tonini GP, Iolascon A, Zappia V and Ragione FD. (2000). Oncogene, 19, 51-60.
6. Host F, Caron L, Marchetti I, Dani C, Marchand-Brustel Y and Binetruy B. (2002). Biochem. J., 361, 621-627.
7. Boudjelal M, Wang Z, Voorhees JJ and Fisher GJ. (2000). Cancer Res., 60, 2247-2252.
8. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P and Gudas LJ. (1995). Mol. Cell. Biol., 15, 843-851.
9. Boyle JO, Langenfeld J, Lonardo F, Sekula D, Reczek P, Rusch V, Dawson MI and Dmitrovsky E. (1999). J. Natl. Cancer Inst., 91, 373-379.
10. Chambon P. (1996). FASEB J., 10, 940-954.
11. Chapellier B, Mark M, Messaddeq N, Calleja C, Warot X, Brocard J, Gerard C, Li M, Metzger D, Ghyselinck NB and Chambon P. (2002). EMBO J., 21, 3402-3413.
12. Chen LC, Tarone R, Huynh M and De Luca LM. (1995). Cancer Lett., 95, 113-118.
13. Chiba H, Clifford J, Metzger D and Chambon P. (1997a). Mol. Cell. Biol., 17, 3013-3020.
14. Chiba H, Clifford J, Metzger D and Chambon P. (1997b). J. Cell. Biol., 139, 735-747.
15. Classon M and Harlow E. (2002). Nat. Rev. Cancer, 2, 910-917.
16. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH and De Luca LM. (1995). Cancer Res., 55, 2774-2782.
17. Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, Collins SJ, De Luca LM and Yuspa SH. (1996). Cancer Res., 56, 4942-4949.
18. De Luca LM, Tarone R, Huynh M, Jones CS and Chen LC. (1996). Nutr. Cancer, 25, 249-257.
19. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F. (2002). Blood, 99, 2199-2206.
20. Faria TN, Mendelsohn C, Chambon P and Gudas LJ. (1999). J. Biol. Chem., 274, 26783-26788.
21. Fisher GJ and Voorhees JJ. (1996). FASEB J., 10, 1002-1013.
22. Fontana JA and Rishi AK. (2002). Leukemia, 16, 463-472.
23. Ghyselinck NB, Dupe V, Dierich A, Messaddeq N, Garnier JM, Rochette-Egly C, Chambon P and Mark M. (1997). Int. J. Dev. Biol., 41, 425-447.
24. Gianni M, Kopf E, Bastien J, Oulad-Abdelghani M, Garattini E, Chambon P and Rochette-Egly C. (2002). J. Biol. Chem., 277, 24859-24862.
25. Gimenez-Conti I, Aldaz CM, Bianchi AB, Roop DR, Slaga TJ and Conti CJ. (1990). Carcinogenesis, 11, 1995-1999.
26. Goyette P, Feng CC, Wang W, Seguin F and Lohnes D. (2000). J. Biol. Chem., 275, 16497-16505.
27. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
28. Hansen LA, Brown D, Virador V, Tanaka T, Andreola F, Strain K, Dancheck B, Riley R, Arbeit JM, De Luca LM, Kogan S and Yuspa SH. (2003). Cancer Res., 63, 5257-5265.
29. Hengartner MO. (2000). Nature, 407, 770-776.
30. Houle B, Rochette-Egly C and Bradley WE. (1993). Proc. Natl. Acad. Sci. USA, 90, 985-989.
31. Houle M, Prinos P, Iulianella A, Bouchard N and Lohnes D. (2000). Mol. Cell. Biol., 20, 6579-6586.
32. Huang C, Ma WY, Dawson MI, Rincon M, Flavell RA and Dong Z. (1997). Proc. Natl. Acad. Sci. USA, 94, 5826-5830.
33. Jochum W, Passegue E and Wagner EF. (2001). Oncogene, 20, 2401-2412.
34. Karin M, Liu Z and Zandi E. (1997). Curr. Opin. Cell. Biol., 9, 240-246.
35. Kastner P, Mark M and Chambon P. (1995). Cell, 83, 859-869.
36. Katz ME and McCormick F. (1997). Curr. Opin. Genet. Dev., 7, 75-79.
37. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH and Der CJ. (1996). Mol. Cell. Biol., 16, 3923-3933.
38. Kinzler KW and Vogelstein B. (1996). Cell, 87, 159-170.
39. Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB and Braakhuis BJ. (2001). Int. J. Cancer, 92, 661-665.
40. Kueng W, Silber E and Eppenberger U. (1989). Anal. Biochem., 182, 16-19.
41. Kumar R, Shoemaker AR and Verma AK. (1994). Carcinogenesis, 15, 701-705.
42. Langenfeld J, Kiyokawa H, Sekula D, Boyle J and Dmitrovsky E. (1997). Proc. Natl. Acad. Sci. USA, 94, 12070-12074.
43. Larcher F, Bauluz C, Diaz-Guerra M, Quintanilla M, Conti CJ, Ballestin C and Jorcano JL. (1992). Mol. Carcinogen, 6, 112-121.
44. Le Q, Dawson MI, Soprano DR and Soprano KJ. (2000). Oncogene, 19, 1457-1465.
45. Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret FX and Kurie JM. (1999). Mol. Cell. Biol., 19, 1973-1980.
46. Liu M, Iavarone A and Freedman LP. (1996). J. Biol. Chem., 271, 31723-31728.
47. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M and Chambon P. (1993). Cell, 73, 643-658.
48. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A and Chambon P. (1994). Development, 120, 2723-2748.
49. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, LeMeur M and Chambon P. (1993). Proc. Natl. Acad. Sci. USA, 90, 7225-7229.
50. Marks R. (1995). Cancer, 75, 607-612.
51. Mehta K. (2003). J. Biol. Regul. Homeost. Agents, 17, 1-12.
52. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P and Mark M. (1994). Development, 120, 2749-2771.
53. Mittnacht S. (1998). Curr. Opin. Genet. Dev., 8, 21-27.
54. Moller MB. (2000). Leukemia Lymphoma, 39, 19-27.
55. Naderi S and Blomhoff HK. (1999). Blood, 94, 1348-1358.
56. Nelson KG and Slaga TJ. (1982). Cancer Res., 42, 4176-4181.
57. Nevins JR. (2001). Hum. Mol. Genet., 10, 699-703.
58. Oridate N, Esumi N, Lotan D, Hing WK, Rochette-Egly C, Chambon P and Lotan R. (1996). Oncogene, 12, 2019-2028.
59. Pepper C, Ali K, Thomas A, Hoy T, Fegan C, Chowdary P, Kell J and Bentley P. (2002). Eur. J. Haematol., 69, 227-235.
60. Philipp J, Vo K, Gurley KE, Seidel K and Kemp CJ. (1999). Oncogene, 18, 4689-4698.
61. Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH and Conti CJ. (1998). Genes Dev., 12, 2469-2474.
62. Rommel C and Hafen E. (1998). Curr. Opin. Genet. Dev., 8, 412-418.
63. Roop DR, Lowy DR, Tambourin PE, Strickland J, Harper JR, Balaschak M, Spangler EF and Yuspa SH. (1986). Nature, 323, 822-824.
64. Ross SA, McCaffery PJ, Drager UC and De Luca LM. (2000). Physiol. Rev., 80, 1021-1054.
65. Sebolt-Leopold JS. (2000). Oncogene, 19, 6594-6599.
66. Shaulian E and Karin M. (2002). Nat. Cell Biol., 4, E131-E136.
67. Sheikh MS, Shao ZM, Li XS, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H and Fontana JA. (1994). J. Biol. Chem., 269, 21440-21447.
68. Stevaux O and Dyson NJ. (2002). Curr. Opin. Cell Biol., 14, 684-691.
69. Sun SY and Lotan R. (2002). Crit. Rev. Oncol. Hematol., 41, 41-55.
70. Taneja R, Bouillet P, Boylan JF, Gaub MP, Roy B, Gudas LJ and Chambon P. (1995). Proc. Natl. Acad. Sci. USA, 92, 7854-7858.
71. Taneja R, Roy B, Plassat JL, Zusi CF, Ostrowski J, Reczek PR and Chambon P. (1996). Proc. Natl. Acad. Sci. USA, 93, 6197-6202.
72. Topley GI, Okuyama R, Gonzales JG, Conti C and Dotto GP. (1999). Proc. Natl. Acad. Sci. USA, 96, 9089-9094.
73. Wang Z, Boudjelal M, Kang S, Voorhees JJ and Fisher GJ. (1999). Nat. Med., 5, 418-422.
74. Webb CP, Van Aelst L, Wigler MH and Woude GF. (1998). Proc. Natl. Acad. Sci. USA, 95, 8773-8778.
75. Wei LN. (2003). Annu. Rev. Pharmacol. Toxicol., 43, 47-72.
76. Weinberg RA. (1995). Cell, 81, 323-330.
77. Weinstein IB. (2002). Science, 297, 63-64.
78. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M and Wigler MH. (1995). Cell, 80, 533-541.
79. Wu JM, DiPietrantonio AM and Hsieh TC. (2001). Apoptosis, 6, 377-388.
80. Xu L, Glass CK and Rosenfeld MG. (1999). Curr. Opin. Genet. Dev., 9, 140-147.
81. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM and Lotan R. (2001). Cancer Res., 61, 4306-4310.
82. Yen A, Roberson MS and Varvayanis S. (1999). In vitro Cell Dev. Biol. Anim., 35, 527-532.
83. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R and Colburn N. (1999). Proc. Natl. Acad. Sci. USA, 96, 9827-9832.
84. Yuspa SH, Dlugosz AA, Denning MF and Glick AB. (1996). J. Invest. Dermatol. Symp. Proc., 1, 147-150.
85. Zhang LX, Mills KJ, Dawson MI, Collins SJ and Jetten AM. (1995). J. Biol. Chem., 270, 6022-6029.
86. Zhang D, Vuocolo S, Masciullo V, Sava T, Giordano A, Soprano DR and Soprano KJ. (2001). Oncogene, 20, 7935-7944.